Skip to main content
SpringerLink
Log in

Response to Kochan et al., 2023

  • Correspondence
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

The Original Article was published on 25 April 2023

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Kochan DC, Novotny PJ, Cathcart-Rake EJ, Orme JJ, Tevaarwerk AJ, Ruddy KJ et al (2023) An evaluation of the effect of lithium on taxane-induced neuropathy. Support Care Cancer 31(5):299

    Article  PubMed  Google Scholar 

  2. Talari K, Goyal M (2020) Retrospective studies - utility and caveats. J R Coll Physicians Edinb 50(4):398–402

    Article  PubMed  Google Scholar 

  3. Tofthagen C (2012) Threats to validity in retrospective studies. J Adv Pract Oncol 3(3):181–183

    PubMed  PubMed Central  Google Scholar 

  4. Schlecker C, Boehmerle W, Jeromin A, DeGray B, Varshney A, Sharma Y et al (2006) Neuronal calcium sensor-1 enhancement of InsP3 receptor activity is inhibited by therapeutic levels of lithium. J Clin Invest 116(6):1668–1674

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Benbow JH, Mann T, Keeler C, Fan C, Hodsdon ME, Lolis E et al (2012) Inhibition of paclitaxel-induced decreases in calcium signaling. J Biol Chem 287(45):37907–37916

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacology, Yale University, 333 Cedar Street, New Haven, CT, 06520-8066, USA

    Barbara E. Ehrlich

  2. Dartmouth Cancer Center, Dartmouth-Hitchcock Medical Center, Dartmouth, MA, USA

    Linda Vahdat

  3. Osmol Therapeutics, New Haven, CT, USA

    Arthur P. DeCillis

  4. Evelyn H. Lauder Breast Center, Memorial Sloan Kettering Cancer Center, New York, NY, USA

    Andrew Seidman

Authors
  1. Barbara E. Ehrlich
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Linda Vahdat
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Arthur P. DeCillis
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Andrew Seidman
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Initial draft was composed by BEE and APD. All authors edited and approved the correspondence.

Corresponding author

Correspondence to Barbara E. Ehrlich.

Ethics declarations

Conflict of interest

BEE is a coFounder and Chief Scientific Advisor, APD is CMO, LV and AS are Consultants for Osmol Therapeutics, a company that is targeting NCS1 for the prevention of CIPN.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ehrlich, B.E., Vahdat, L., DeCillis, A.P. et al. Response to Kochan et al., 2023. Support Care Cancer 31, 486 (2023). https://doi.org/10.1007/s00520-023-07950-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s00520-023-07950-w

Search

Navigation